via NEWS am Medicine
Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
Learn more: Mayo Clinic doctors: Fecal transplants may be best answer to antibiotic-resistant bacteria
The Latest on: Fecal transplants
via Google News
The Latest on: Fecal transplants
- Scientists Are Using Data From Olympic Athletes to Help Average Joes Get Healthieron July 31, 2022 at 12:00 pm
With the goal of sharing the genetic wonders—and matter—of top athletes with the rest of us, scientist are making cutting-edge advancements.
- Fecal Transplant in UC; Cancer Surveillance Lacking in Cirrhosis; Undiagnosed Celiacon July 28, 2022 at 11:04 am
Zaina Hamza, Staff Writer, MedPage Today July 28, 2022 Researchers believe they've identified two more reasons why fecal microbiota transplants from certain donors more often induce ulcerative colitis ...
- Researchers say freezing your fecal matter at a young age has future life-saving potentialon July 26, 2022 at 3:18 pm
In an article published in Trends in Molecular Medicine, Harvard scientists suggest preserving stool at a young age may prove to be life-saving in the future. The method is called autologous fecal ...
- Fecal Transplants See Success in 90 Percent of Bacterial Gut Infectionson July 25, 2022 at 5:00 pm
diff) infection, which causes severe diarrhea in sufferers. Fecal transplants are meant to take the microbiomes of healthy donors and allow them to flourish in the recipients, killing any C.
- Controversy intensifies over fecal transplantationon July 22, 2022 at 3:28 am
In addition, they stressed that further research is needed on the long-term effects of fecal transplants. They noted that regulating fecal transplants as a tissue is likely to facilitate improved ...
- Building a poop bank for human fecal transplantson July 10, 2022 at 12:48 am
If something goes wrong, that often means relying on borrowing a microbiome jump start from a stranger by way of a fecal transplant. Not to put too fine a point on it, but that process involves ...
- Cambridge microbiome company looks beyond fecal transplantson July 6, 2022 at 3:52 pm
Three Boston firms are racing to develop pills based on a medical procedure called fecal microbiota transplant, in which feces from a healthy individual — teeming with good gut bacteria — are ...
- Lawyer of naturopath who produced fecal transplant material to treat autism claims he’s 'not bound by science'on July 4, 2022 at 7:23 am
Reports indicate the naturopath was using fecal microbiota transplantation, or fecal transplants, to treat symptoms of autism, constipation and other diagnoses at his clinic in Mexico. A lawyer for a ...
via Bing News